PAHC - CIK 0001069899
PHIBRO ANIMAL HEALTH CORP trades as PAHC and has a market capitalization of $2.16 B, making it the #2048 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $1.30B, up 27.4% from the prior year and net income of $48.26M. This page tracks PHIBRO ANIMAL HEALTH CORP through 733 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years PHIBRO ANIMAL HEALTH CORP's revenue grew from $751.53M to $1.30B, a compound annual growth rate of 6.2%. Net profit margin compressed from 11.0% to 3.7% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13D/A | - | 2026-05-22 |
| Insider trade | 4 | 2026-05-07 |
| Major company event | 8-K | 2026-05-06 |
| Quarterly report | 10-Q | 2026-05-06 |
| Major company event | 8-K | 2026-05-05 |
| SCHEDULE 13G | - | 2026-04-30 |
| Insider trade | 4 | 2026-04-30 |
| Major company event | 8-K | 2026-04-30 |
Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America Securities Health Care Conference.
Net sales of $383.5 million, an increase of $35.7 million, or 10%
Net sales of $373.9 million, an increase of $64.6 million, or 21%
The largest companies sharing PHIBRO ANIMAL HEALTH CORP's SEC industry classification (pharmaceutical preparations).
PHIBRO ANIMAL HEALTH CORP (PAHC) has a market capitalization of $2.16 B as of 2026-06-10, ranking #2048 among US-listed companies.
PHIBRO ANIMAL HEALTH CORP reported revenue of $1.30B for fiscal year 2025, an increase of 27.4% year over year.
Yes. PHIBRO ANIMAL HEALTH CORP reported net income of $48.26M in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.